FLEURY S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.53 BRL | +3.71% |
|
+0.83% | -19.24% |
| May. 10 | Fleury Seeks Acquisitions | CI |
| May. 10 | Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024 |
ETFs positioned on Fleury S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.43% | 2 M€ | -14.14% | ||
| 0.24% | 14 M€ | -1.33% | ||
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 112 M€ | +5.33% | - | |
| 0.00% | 45 M€ | 0.00% | - | |
| 0.00% | 7 M€ | +6.24% | - | |
| 0.00% | 34 M€ | +4.26% | - |
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
Calendar
2024-06-04
- Bradesco BBI London Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
14.67
BRL
Average target price
19.33
BRL
Spread / Average Target
+31.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.24% | 1.56B | |
| -16.99% | 8.67B | |
| +65.26% | 4.25B | |
| -1.10% | 2.51B | |
| -9.46% | 2.47B | |
| -44.11% | 2.25B | |
| -8.71% | 1.91B | |
| -41.75% | 1.19B | |
| +11.31% | 1.15B | |
| +14.87% | 964M |
- Stock Market
- Equities
- FLRY3 Stock
- Funds and ETFs Fleury S.A.
